Cargando…

New-onset ascites as a manifestation of virologic relapse in patients with hepatitis C cirrhosis

BACKGROUND: Chronic hepatitis C is the most common cause of cirrhosis in industrialized countries. Successful treatment of chronic hepatitis C in patients with advanced fibrosis or cirrhosis has significant benefits, including improvements in inflammation, fibrosis, and portal hypertension, with pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Chua, Deborah Lim, Hahambis, Thomas, Sigal, Samuel H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953743/
https://www.ncbi.nlm.nih.gov/pubmed/24696626
http://dx.doi.org/10.2147/HMER.S53604
_version_ 1782307409484578816
author Chua, Deborah Lim
Hahambis, Thomas
Sigal, Samuel H
author_facet Chua, Deborah Lim
Hahambis, Thomas
Sigal, Samuel H
author_sort Chua, Deborah Lim
collection PubMed
description BACKGROUND: Chronic hepatitis C is the most common cause of cirrhosis in industrialized countries. Successful treatment of chronic hepatitis C in patients with advanced fibrosis or cirrhosis has significant benefits, including improvements in inflammation, fibrosis, and portal hypertension, with prevention of esophageal varices and clinical decompensation. CASE: In this report, we present two patients with well-compensated hepatitis C cirrhosis who achieved an end-of-treatment response on a direct-acting antiviral therapy-based triple regimen for hepatitis C virus, but subsequently presented with new-onset ascites associated with virologic relapse. CONCLUSION: We propose that the development of ascites in this setting is due to the adverse impact of inflammation of the virologic relapse on portal hypertension. Our observation that ascites formation can be a manifestation of virologic relapse has potentially important clinical implications, as it highlights not only the importance of close monitoring of cirrhotic patients after achieving end-of-treatment response but also the impact of active inflammation on the severity of portal hypertension.
format Online
Article
Text
id pubmed-3953743
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-39537432014-04-02 New-onset ascites as a manifestation of virologic relapse in patients with hepatitis C cirrhosis Chua, Deborah Lim Hahambis, Thomas Sigal, Samuel H Hepat Med Case Series BACKGROUND: Chronic hepatitis C is the most common cause of cirrhosis in industrialized countries. Successful treatment of chronic hepatitis C in patients with advanced fibrosis or cirrhosis has significant benefits, including improvements in inflammation, fibrosis, and portal hypertension, with prevention of esophageal varices and clinical decompensation. CASE: In this report, we present two patients with well-compensated hepatitis C cirrhosis who achieved an end-of-treatment response on a direct-acting antiviral therapy-based triple regimen for hepatitis C virus, but subsequently presented with new-onset ascites associated with virologic relapse. CONCLUSION: We propose that the development of ascites in this setting is due to the adverse impact of inflammation of the virologic relapse on portal hypertension. Our observation that ascites formation can be a manifestation of virologic relapse has potentially important clinical implications, as it highlights not only the importance of close monitoring of cirrhotic patients after achieving end-of-treatment response but also the impact of active inflammation on the severity of portal hypertension. Dove Medical Press 2014-01-29 /pmc/articles/PMC3953743/ /pubmed/24696626 http://dx.doi.org/10.2147/HMER.S53604 Text en © 2014 Chua et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Case Series
Chua, Deborah Lim
Hahambis, Thomas
Sigal, Samuel H
New-onset ascites as a manifestation of virologic relapse in patients with hepatitis C cirrhosis
title New-onset ascites as a manifestation of virologic relapse in patients with hepatitis C cirrhosis
title_full New-onset ascites as a manifestation of virologic relapse in patients with hepatitis C cirrhosis
title_fullStr New-onset ascites as a manifestation of virologic relapse in patients with hepatitis C cirrhosis
title_full_unstemmed New-onset ascites as a manifestation of virologic relapse in patients with hepatitis C cirrhosis
title_short New-onset ascites as a manifestation of virologic relapse in patients with hepatitis C cirrhosis
title_sort new-onset ascites as a manifestation of virologic relapse in patients with hepatitis c cirrhosis
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953743/
https://www.ncbi.nlm.nih.gov/pubmed/24696626
http://dx.doi.org/10.2147/HMER.S53604
work_keys_str_mv AT chuadeborahlim newonsetascitesasamanifestationofvirologicrelapseinpatientswithhepatitisccirrhosis
AT hahambisthomas newonsetascitesasamanifestationofvirologicrelapseinpatientswithhepatitisccirrhosis
AT sigalsamuelh newonsetascitesasamanifestationofvirologicrelapseinpatientswithhepatitisccirrhosis